Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Saved in:
| Title: | Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. |
|---|---|
| Authors: | Yamashita, Akihiro, Morioka, Miho, Kishi, Hiromi, Yahara, Yasuhito, Okada, Minoru, Fujita, Kaori, Kimura, Takeshi, Sawai, Hideaki, Ikegawa, Shiro, Tsumaki, Noriyuki |
| Source: | Nature. 9/25/2014, Vol. 513 Issue 7519, p507-511. 5p. 4 Graphs. |
| Subjects: | Statins (Cardiovascular agents), Skeletal dysplasia, Achondroplasia, Dysplasia, Fibroblast growth factor receptors, Therapeutics |
| Abstract: | Gain-of-function mutations in the fibroblast growth factor receptor 3 gene (FGFR3) result in skeletal dysplasias, such as thanatophoric dysplasia and achondroplasia (ACH). The lack of disease models using human cells has hampered the identification of a clinically effective treatment for these diseases. Here we show that statin treatment can rescue patient-specific induced pluripotent stem cell (iPSC) models and a mouse model of FGFR3 skeletal dysplasia. We converted fibroblasts from thanatophoric dysplasia type I (TD1) and ACH patients into iPSCs. The chondrogenic differentiation of TD1 iPSCs and ACH iPSCs resulted in the formation of degraded cartilage. We found that statins could correct the degraded cartilage in both chondrogenically differentiated TD1 and ACH iPSCs. Treatment of ACH model mice with statin led to a significant recovery of bone growth. These results suggest that statins could represent a medical treatment for infants and children with TD1 and ACH. [ABSTRACT FROM AUTHOR] |
| Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 98526091 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yamashita%2C+Akihiro%22">Yamashita, Akihiro</searchLink><br /><searchLink fieldCode="AR" term="%22Morioka%2C+Miho%22">Morioka, Miho</searchLink><br /><searchLink fieldCode="AR" term="%22Kishi%2C+Hiromi%22">Kishi, Hiromi</searchLink><br /><searchLink fieldCode="AR" term="%22Yahara%2C+Yasuhito%22">Yahara, Yasuhito</searchLink><br /><searchLink fieldCode="AR" term="%22Okada%2C+Minoru%22">Okada, Minoru</searchLink><br /><searchLink fieldCode="AR" term="%22Fujita%2C+Kaori%22">Fujita, Kaori</searchLink><br /><searchLink fieldCode="AR" term="%22Kimura%2C+Takeshi%22">Kimura, Takeshi</searchLink><br /><searchLink fieldCode="AR" term="%22Sawai%2C+Hideaki%22">Sawai, Hideaki</searchLink><br /><searchLink fieldCode="AR" term="%22Ikegawa%2C+Shiro%22">Ikegawa, Shiro</searchLink><br /><searchLink fieldCode="AR" term="%22Tsumaki%2C+Noriyuki%22">Tsumaki, Noriyuki</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Nature%22">Nature</searchLink>. 9/25/2014, Vol. 513 Issue 7519, p507-511. 5p. 4 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Statins+%28Cardiovascular+agents%29%22">Statins (Cardiovascular agents)</searchLink><br /><searchLink fieldCode="DE" term="%22Skeletal+dysplasia%22">Skeletal dysplasia</searchLink><br /><searchLink fieldCode="DE" term="%22Achondroplasia%22">Achondroplasia</searchLink><br /><searchLink fieldCode="DE" term="%22Dysplasia%22">Dysplasia</searchLink><br /><searchLink fieldCode="DE" term="%22Fibroblast+growth+factor+receptors%22">Fibroblast growth factor receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Gain-of-function mutations in the fibroblast growth factor receptor 3 gene (FGFR3) result in skeletal dysplasias, such as thanatophoric dysplasia and achondroplasia (ACH). The lack of disease models using human cells has hampered the identification of a clinically effective treatment for these diseases. Here we show that statin treatment can rescue patient-specific induced pluripotent stem cell (iPSC) models and a mouse model of FGFR3 skeletal dysplasia. We converted fibroblasts from thanatophoric dysplasia type I (TD1) and ACH patients into iPSCs. The chondrogenic differentiation of TD1 iPSCs and ACH iPSCs resulted in the formation of degraded cartilage. We found that statins could correct the degraded cartilage in both chondrogenically differentiated TD1 and ACH iPSCs. Treatment of ACH model mice with statin led to a significant recovery of bone growth. These results suggest that statins could represent a medical treatment for infants and children with TD1 and ACH. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=98526091 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/nature13775 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 507 Subjects: – SubjectFull: Statins (Cardiovascular agents) Type: general – SubjectFull: Skeletal dysplasia Type: general – SubjectFull: Achondroplasia Type: general – SubjectFull: Dysplasia Type: general – SubjectFull: Fibroblast growth factor receptors Type: general – SubjectFull: Therapeutics Type: general Titles: – TitleFull: Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yamashita, Akihiro – PersonEntity: Name: NameFull: Morioka, Miho – PersonEntity: Name: NameFull: Kishi, Hiromi – PersonEntity: Name: NameFull: Yahara, Yasuhito – PersonEntity: Name: NameFull: Okada, Minoru – PersonEntity: Name: NameFull: Fujita, Kaori – PersonEntity: Name: NameFull: Kimura, Takeshi – PersonEntity: Name: NameFull: Sawai, Hideaki – PersonEntity: Name: NameFull: Ikegawa, Shiro – PersonEntity: Name: NameFull: Tsumaki, Noriyuki IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 09 Text: 9/25/2014 Type: published Y: 2014 Identifiers: – Type: issn-print Value: 00280836 Numbering: – Type: volume Value: 513 – Type: issue Value: 7519 Titles: – TitleFull: Nature Type: main |
| ResultId | 1 |